Dr. Klasko is a special advisor at General Catalyst, where he plays a key role in helping the firm identify and invest in innovative healthcare solutions aimed at improving access and outcomes. He joined the venture capital firm in 2022. Prior to that, he was president and CEO of Philadelphia-based Jefferson Health for eight years.
Dr. Klasko succeeds Steven Katz, who resigned from the DocGo board Sept. 25. Mr. Katz will remain on as consultant through the end of the year to ensure a smooth transition, according to a Sept. 30 news release sent to Becker’s.
DocGo, a telehealth and mobile health company, is worth $3.6 billion, placing it among the 12 most valuable digital health companies.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
